When you excel at advanced endovascular techniques only to have patients’ outcomes and recovery affected by a VCD that leaves something behind, it’s time make a change. SiteSeal is a simple-to-use, atraumatic, single VCD that establishes hemostasis, all with a minimal complication rate. Designed for use on patients of all shapes and sizes, SiteSeal closes the artery and leaves nothing behind within the vessel, vessel wall, or surrounding tissue. SiteSeal can close any size vascular access sheath and multiple sheaths within a single vessel for EP procedures. The ideal VCD you wish existed, now does. FDA Market Approval.
SiteSeal is a vascular closure device designed to simulate external compression, but removes the associated variables and risk of unnecessary complications.
When post-endovascular procedure hemostasis from manual compression takes up a third of a professional’s time and introduces significant variability, it’s time for a new standard of care. SiteSeal is a VCD that can ambulate patients in approximately one hour for diagnostic procedures, and approximately two hours for interventional procedures unless modified by physician, while they lie more comfortably with their heads at a 30-degree angle and allows free leg movement. A VCD that frees up your hands and valuable time? It’s here.
With the growth rate of AF procedures at a level of 13.5% per year, Ensite Vascular has the single VCD device available to EP physicians with the stand-alone feature of being able to close multiple sheaths within a single vessel for EP procedures while leaving nothing behind within the vessel, vessel wall, or surrounding soft tissue.
SiteSeal is designed for use on patients of all shapes and sizes, including morbidly obese patients and those with calcification.